Lv4
490 积分 2023-08-28 加入
Non-invasive tests of fibrosis in the management of MASLD: revolutionising diagnosis, progression and regression monitoring
16天前
已完结
Long-Term Glycemic Control and the Risk of Liver Stiffness Progression and Liver-Related Events in MASLD
18天前
已完结
Global Prevalence, Incidence, and Outcomes of Coexisting MASLD and Chronic Kidney Disease: A Meta‐Analysis
18天前
已完结
Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD
19天前
已完结
MASLD Is Associated With an Increased Long‐Term Risk of Atrial Fibrillation: An Updated Systematic Review and Meta‐Analysis
19天前
已完结
Two‐tier screening approach for liver fibrosis stratification in outpatients with type 2 diabetes mellitus: A multicenter cross‐sectional study
19天前
已完结
Resolving Metabolic Dysfunction-associated Steatotic Liver Disease Reduces Subclinical Cardiovascular Damage in Chinese Youths
19天前
已完结
Projected Global Clinical, Humanistic, and Economic Impact of Metabolic Dysfunction-Associated Steatohepatitis (MASH): The Cost of Inaction Based on Data From Nine Countries
19天前
已完结
Metabolic Dysfunction-Associated Steatohepatitis in the Middle East: Clinical Challenges and Strategies to Bridge the Gap
23天前
已完结
Metabolic Dysfunction Associated Steatohepatitis (MASH) in Oceania, Central America, and the Caribbean
23天前
已完结
皖公网安备34019202002308
